{"status": "OK", "response": {"docs": [{"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: Re ''Now End the Racial Bias in Health Care'' (letters, March 28): Our board monitors more than 50 quality-of-care measures. The results demonstrate that it is possible to markedly improve quality of care even in minority populations. For example, we screen 90 percent of all eligible women for breast cancer. This is 20 percent higher than the national rate for white populations.", "headline": {"main": "Minority Health Care"}, "abstract": "Letter by Richard T Roberts and Dr Benjamin Chu of New York City Health and Hospitals Corp explains efforts to provide care to minorities (S)", "print_page": "22", "word_count": 136, "_id": "4fd22e9c8eb7c8105d7bc857", "snippet": "To the Editor:    Re ''Now End the Racial Bias in Health Care'' (letters, March 28):    Our board monitors more than 50 quality-of-care measures. The results demonstrate that it is possible to markedly improve quality of care even in minority...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/04/02/opinion/l-minority-health-care-338001.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CHU, BENJAMIN"}, {"name": "persons", "value": "ROBERTS, RICHARD T"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "organizations", "value": "HEALTH AND HOSPITALS CORP"}, {"name": "subject", "value": "MINORITIES (US)"}, {"name": "subject", "value": "BLACKS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "2002-04-02T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The Overseas Private Investment Corporation has asked the Justice Department to examine whether Enron misrepresented its financial condition in obtaining more than $1 billion in taxpayer-backed financing and insurance for international projects, a step that could lead the agency to pull its support for some foreign deals. In the aftermath of Enron's collapse, OPIC is also reassessing the size and nature of projects that it will support, according to its chairman, Peter S. Watson, a Bush administration appointee. The agency, long a target of critics who view it as unnecessary or wasteful, seeks to increase American exports and investment overseas by providing loans and insuring companies against the risk that foreign nations will fail to pay them for building power plants or other major facilities outside of American territory.", "headline": {"main": "Loan Agency Wants Inquiry Into Enron"}, "abstract": "Overseas Private Investment Corp asks Justice Department to examine whether Enron Corp misrepresented its financial condition in obtaining more than $1 billion in taxpayer-backed financing and insurance for international projects, step that could lead agency to pull its support for some foreign deals; OPIC chairman Peter S Wilson says agency is also reassessing size and nature of projects that it will support; OPIC's actions are also expansion of federal inquiries into Enron and its former executives; Bush administration probably has little to lose in pursuing investigation of projects it did not begin, and OPIC's ties to Enron during Clinton administration years; chart; photo (M)", "print_page": "1", "word_count": 937, "_id": "4fd234198eb7c8105d7c4e53", "snippet": "The Overseas Private Investment Corporation has asked the Justice Department to examine whether Enron misrepresented its financial condition in obtaining more than $1 billion in taxpayer-backed financing and insurance for international projects, a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/04/02/business/loan-agency-wants-inquiry-into-enron.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "WILSON, PETER S"}, {"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "organizations", "value": "ENRON CORP"}, {"name": "organizations", "value": "OVERSEAS PRIVATE INVESTMENT CORP"}, {"name": "subject", "value": "FOREIGN INVESTMENTS"}, {"name": "subject", "value": "ACCOUNTING AND ACCOUNTANTS"}, {"name": "subject", "value": "UNITED STATES POLITICS AND GOVERNMENT"}, {"name": "subject", "value": "ENERGY AND POWER"}, {"name": "subject", "value": "OIL (PETROLEUM) AND GASOLINE"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "ELECTRIC LIGHT AND POWER"}, {"name": "subject", "value": "BANKRUPTCIES"}], "byline": {"person": [{"qualifier": "Jr.", "firstname": "Richard", "middlename": "A.", "lastname": "OPPEL", "rank": 1, "role": "reported", "organization": ""}, {"firstname": "David", "middlename": "E.", "lastname": "SANGER", "rank": 2, "role": "reported", "organization": ""}], "original": "By RICHARD A. OPPEL Jr. and DAVID E. SANGER"}, "document_type": "article", "pub_date": "2002-04-02T00:00:00Z", "section_name": "Business; Washington"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: ''Answering '800' Calls, Extra Income but No Security'' (front page, March 27) describes how ''even as the economy boomed in the late 1990's,'' call centers' ''pay scales held steady.'' I read this just after an interesting realization in my psychology practice. A patient I had seen in 1994 just consulted me again this week. In reviewing his records, I saw that he had the same insurance as in 1994 (a major national health plan) -- and that the amount I will be paid now is exactly the same as in 1994. Needless to say, all of my expenses have increased since 1994. This situation is no doubt the same for most health care providers.", "headline": {"main": "So Reimburse Me!"}, "abstract": "John G Guinan letter on March 27 article about wages for call center workers cites other example of stagnant pay", "print_page": "18", "word_count": 145, "_id": "4fd273328eb7c8105d83094e", "snippet": "To the Editor:    ''Answering '800' Calls, Extra Income but No Security'' (front page, March 27) describes how ''even as the economy boomed in the late 1990's,'' call centers' ''pay scales held steady.''     I read this just after an interesting...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/04/01/opinion/l-so-reimburse-me-299979.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GUINAN, JOHN G"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "WAGES AND SALARIES"}, {"name": "subject", "value": "TELEPHONES AND TELECOMMUNICATIONS"}], "byline": null, "document_type": "article", "pub_date": "2002-04-01T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The soaring cost of prescription drugs has emerged as a potent domestic political issue, not only nationally, but also at the state level. Bills to deal with the cost of drugs are under consideration in 37 state legislatures. On Capitol Hill, legislative leaders in both parties are vying to portray themselves as the better protectors of older people and other consumers against rising pharmaceutical prices, with spending on outpatient prescription drugs up 17.1 percent last year.", "headline": {"main": "Rising Drug Costs a Powerful Issue For National and State Politicians"}, "abstract": "Soaring cost of prescription drugs emerges as potent domestic political issue, not only nationally, but also at state level; in election year in which no domestic issue has become centerpiece of voter concern, some strategists say issue, particularly its impact on older people, will loom large in fall campaign and maybe even longer; bills to deal with cost of drugs are under consideration in 37 state legislatures, while on Capitol Hill leaders of both parties are vying to portray themselves as better protectors of older people and other consumers; Business for Affordable Medicine--new coalition of employers, governors and organized labor--is lobbying on Capitol Hill for overhaul of law governing pharmaceutical competition and generic drugs, arguing that current law makes it too easy for industry to stifle competition (M)", "print_page": "1", "word_count": 1104, "_id": "4fd268c28eb7c8105d81f469", "snippet": "The soaring cost of prescription drugs has emerged as a potent domestic political issue, not only nationally, but also at the state level.    Bills to deal with the cost of drugs are under consideration in 37 state legislatures. On Capitol Hill,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/04/01/us/rising-drug-costs-a-powerful-issue-for-national-and-state-politicians.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "BUSINESS FOR AFFORDABLE MEDICINE"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "ANTITRUST ACTIONS AND LAWS"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "ORGANIZED LABOR"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "ELECTIONS"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robin", "lastname": "TONER"}], "original": "By ROBIN TONER"}, "document_type": "article", "pub_date": "2002-04-01T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 24, "offset": 20, "time": 65}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}